AAAAAA
Results:
1-25
|
Results: 25
Authors:
Kelly, K
Lovato, L
Bunn, PA
Livingston, RB
Zangmeister, J
Taylor, SA
Roychowdhury, D
Crowley, JJ
Gandara, DR
Citation: K. Kelly et al., Cisplatin, etoposide, and paclitaxel with granulocyte colony-stimulating factor in untreated patients with extensive-stage small cell lung cancer: A phase II trial of the southwest oncology group, CLIN CANC R, 7(8), 2001, pp. 2325-2329
Authors:
Combs, DR
Livingston, RB
Citation: Dr. Combs et Rb. Livingston, Psychological sub-types among persons with HIV infection: an empirical study, AIDS CARE, 13(2), 2001, pp. 157-162
Authors:
Schiller, JH
Adak, S
Feins, RH
Keller, SM
Fry, WA
Livingston, RB
Hammond, MEM
Wolf, B
Sabatini, L
Jett, J
Kohman, L
Johnson, DH
Citation: Jh. Schiller et al., Lack of prognostic significance of p53 and K-ras mutations in primary resected non-small-cell lung cancer on E4592: A laboratory ancillary study on an Eastern Cooperative Oncology Group prospective randomized trial of postoperative adjuvant therapy, J CL ONCOL, 19(2), 2001, pp. 448-457
Authors:
Gralow, JR
Livingston, RB
Citation: Jr. Gralow et Rb. Livingston, University of Washington high-dose cyclophosphamide, mitoxantrone, and etoposide experience in metastatic breast cancer: Unexpected cardiac toxicity, J CL ONCOL, 19(18), 2001, pp. 3903-3904
Authors:
Eubank, WB
Mankoff, DA
Takasugi, J
Vesselle, H
Eary, JF
Shanley, TJ
Gralow, JR
Charlop, A
Ellis, GK
Lindsley, KL
Austin-Seymour, MM
Funkhouser, CP
Livingston, RB
Citation: Wb. Eubank et al., (18)Fluorodeoxyglucose positron emission tomography to detect mediastinal or internal mammary metastases in breast cancer, J CL ONCOL, 19(15), 2001, pp. 3516-3523
Authors:
Kelly, K
Crowley, J
Bunn, PA
Presant, CA
Grevstad, PK
Mainpour, CM
Ramsey, SD
Wozniak, AJ
Weiss, GR
Moore, DF
Israel, VK
Livingston, RB
Gandara, DR
Citation: K. Kelly et al., Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non-small-celllung cancer: A Southwest Oncology Group trial, J CL ONCOL, 19(13), 2001, pp. 3210-3218
Authors:
Gabrilove, JL
Cleeland, CS
Livingston, RB
Sarokhan, B
Winer, E
Einhorn, LH
Citation: Jl. Gabrilove et al., Clinical evaluation of once-weekly dosing of epoetin alfa in chemotherapy patients: Improvements in hemoglobin and quality of life are similar to three-times-weekly dosing, J CL ONCOL, 19(11), 2001, pp. 2875-2882
Authors:
Thomas, CR
Giroux, DJ
Janaki, LM
Turrisi, AT
Crowley, JJ
Taylor, SA
McCracken, JD
Giri, PGS
Gordon, W
Livingston, RB
Gandara, DR
Citation: Cr. Thomas et al., Ten-year follow-up of Southwest Oncology Group 8269: a phase II trial of concomitant cisplatin - etoposide and daily thoracic radiotherapy in limitedsmall-cell lung cancer, LUNG CANC, 33(2-3), 2001, pp. 213-219
Authors:
Livingston, RB
Gray, RM
Broquie, JAP
Dickson, TL
Collins, AL
Spence, S
Citation: Rb. Livingston et al., Construct validity of Wechsler factor scores, PERC MOT SK, 93(1), 2001, pp. 78-80
Authors:
Pritchard, DA
Livingston, RB
Reynolds, CR
Moses, JA
Citation: Da. Pritchard et al., Modal profiles for the WISC-III, SCH PSYCH Q, 15(4), 2000, pp. 400-418
Authors:
Livingston, RB
Citation: Rb. Livingston, Timing of antitubulin therapy: Does it matter?, CANCER INV, 18(8), 2000, pp. 804-805
Authors:
Bellon, JR
Lindsley, KL
Ellis, GK
Gralow, JR
Livingston, RB
Seymour, MMA
Citation: Jr. Bellon et al., Concurrent radiation therapy and paclitaxel or docetaxel chemotherapy in high-rise breast cancer, INT J RAD O, 48(2), 2000, pp. 393-397
Authors:
Gutierrez-Delgado, F
Holmberg, LA
Hooper, H
Appelbaum, FR
Livingston, RB
Maziarz, RT
Weiden, P
Rivkin, S
Montgomery, P
Kawahara, K
Bensinger, W
Citation: F. Gutierrez-delgado et al., High-dose busulfan, melphalan and thiotepa as consolidation for noninflammatory high-risk breast cancer, BONE MAR TR, 26(1), 2000, pp. 51-59
Authors:
Gray, RM
Livingston, RB
Marshall, RM
Haak, RA
Citation: Rm. Gray et al., Reference group data for the Reitan-Indiana Neuropsychological Test Battery for Young Children, PERC MOT SK, 91(2), 2000, pp. 675-682
Authors:
Keller, SM
Adak, S
Wagner, H
Herskovic, A
Komaki, R
Brooks, BJ
Perry, MC
Livingston, RB
Johnson, DH
Citation: Sm. Keller et al., A randomized trial of postoperative adjuvant therapy in patients with completely resected stage II or IIIa non-small-cell lung cancer., N ENG J MED, 343(17), 2000, pp. 1217-1222
Authors:
Yuen, AR
Zou, GY
Turrisi, AT
Sause, W
Komaki, R
Wagner, H
Aisner, SC
Livingston, RB
Blum, R
Johnson, DH
Citation: Ar. Yuen et al., Similar outcome of elderly patients in intergroup trial 0096 - Cisplatin, etoposide, and thoracic radiotherapy administered once or twice daily in limited stage small cell lung carcinoma, CANCER, 89(9), 2000, pp. 1953-1960
Authors:
Hesketh, PJ
Crowley, JJ
Burris, HA
Williamson, SK
Balcerzak, SP
Peereboom, D
Goodwin, JW
Gross, HM
Moore, DF
Livingston, RB
Gandara, DR
Citation: Pj. Hesketh et al., Evaluation of docetaxel in previously untreated extensive-stage small celllung cancer: A Southwest Oncology Group phase II trial, CA J SCI AM, 5(4), 1999, pp. 237-241
Authors:
Livingston, RB
Gray, RM
Haak, RA
Citation: Rb. Livingston et al., Internal consistency of three tests from the Halstead-Reitan Neuropsychological Battery for Older Children, ASSESSMENT, 6(1), 1999, pp. 93-99
Authors:
Livingston, RB
Citation: Rb. Livingston, What is the role of radiation therapy in locally advanced non-small-cell lung cancer?, ANN ONCOL, 10(3), 1999, pp. 259-260
Authors:
Murray, N
Livingston, RB
Shepherd, FA
James, K
Zee, B
Langleben, A
Kraut, M
Bearden, J
Goodwin, JW
Grafton, C
Turrisi, A
Walde, D
Croft, H
Osoba, D
Ottaway, J
Gandara, D
Citation: N. Murray et al., Randomized study of CODE versus alternating CAV/EP for extensive-stage small-cell lung cancer: An intergroup study of the National Cancer Institute of Canada Clinical Trials Group and the Southwest Oncology Group, J CL ONCOL, 17(8), 1999, pp. 2300-2308
Authors:
Ellis, GK
Gralow, JR
Pierce, HI
Williams, MA
Livingston, RB
Citation: Gk. Ellis et al., Infusional paclitaxel and weekly vinorelbine chemotherapy with concurrent filgrastim for metastatic breast cancer: High complete response rate in a phase I-II study of doxorubicin-treated patients, J CL ONCOL, 17(5), 1999, pp. 1407-1412
Authors:
Ellis, GK
Green, S
Livingston, RB
Kraut, MJ
Pierce, HI
Paradelo, JC
Taylor, SA
Martino, S
Citation: Gk. Ellis et al., 'Neo-FAC' (5-fluorouracil, doxorubicin, and cyclophosphamide) for poor-prognosis stage IV breast cancer - A Southwest Oncology Group phase II study, AM J CL ONC, 22(5), 1999, pp. 446-449
Authors:
Turrisi, AT
Kim, K
Blum, R
Sause, WT
Livingston, RB
Komaki, R
Wagner, H
Aisner, S
Johnson, DH
Citation: At. Turrisi et al., Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide, N ENG J MED, 340(4), 1999, pp. 265-271
Authors:
Mankoff, DA
Dunnwald, LK
Gralow, JR
Ellis, GK
Drucker, MJ
Livingston, RB
Citation: Da. Mankoff et al., Monitoring the response of patients with locally advanced breast carcinomato neoadjuvant chemotherapy using [technetium 99m]-sestamibi scintimammography, CANCER, 85(11), 1999, pp. 2410-2423
Authors:
Livingston, RB
Citation: Rb. Livingston, Concurrent G-CSF and chemotherapy, J CL ONCOL, 16(12), 1998, pp. 3917-3917
Risultati:
1-25
|